Reuters logo
BRIEF-Genscript Biotech updates on development of new drug​
May 29, 2017 / 12:53 AM / 6 months ago

BRIEF-Genscript Biotech updates on development of new drug​

May 29 (Reuters) - Genscript Biotech Corp

* ‍application for clinical trial on KLT-1101 was accepted by China food and drug administration on 4 May 2017.​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below